ReviewArchives of microbiology2026
Pharmaceutical innovation in advanced nanomedicine for the treatment of hypervirulent and multidrug-resistant Klebsiella pneumoniae infections.
Helal F Hetta et al.PubMed ↗Publisher ↗
No numbers read from the abstract.